Glaukos (NYSE:GKOS – Free Report) had its price objective boosted by Wells Fargo & Company from $153.00 to $160.00 in a ...

Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) is expected to be announcing its earnings results before the market opens on Tuesday, February 25th. Analysts expect the company to announce ...

BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth.

BTIG analyst Marvin Fong maintained a Buy rating on Mercadolibre (MELI – Research Report) today and set a price target of $2,500.00. The ...

In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...

Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted ...

BTIG highlights Wingstop (WING) as a top pick ahead of earnings, citing strong unit growth, supply chain benefits, & robust ...

On Tuesday, BTIG analyst Thomas Catherwood maintained a Neutral rating on shares of Kilroy Realty Corporation (NYSE:KRC), following the company's release of its fourth-quarter 2024 financial results.

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage highlighted ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...